Thus, while exploring the modulation of the p53 pathway with oligonol has presented a promising avenue in liver disease research, the intertwined roles of p53 in both liver fibrosis and cancer mandate a judicious and knowledgeable approach. This evidence concerns the gene TP53 and cancer.